Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
Authors
Keywords
-
Journal
BRAIN
Volume 135, Issue 6, Pages 1819-1833
Publisher
Oxford University Press (OUP)
Online
2012-05-05
DOI
10.1093/brain/aws105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beneficial Plasma Exchange Response in Central Nervous System Inflammatory Demyelination
- (2011) Setty M. Magaña ARCHIVES OF NEUROLOGY
- Autoimmune disorders affecting both the central and peripheral nervous system
- (2011) Christoph Kamm et al. AUTOIMMUNITY REVIEWS
- Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
- (2011) Simone Mader et al. Journal of Neuroinflammation
- Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
- (2011) A. K. Probstel et al. NEUROLOGY
- The role of antibodies in multiple sclerosis
- (2010) Martin S. Weber et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury
- (2010) Tobias Derfuss et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Humoral autoimmunity in multiple sclerosis
- (2010) Edgar Meinl et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children
- (2010) PH Lalive et al. Multiple Sclerosis Journal
- AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
- (2010) Sven Jarius et al. Nature Reviews Neurology
- Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
- (2009) Monika Bradl et al. ANNALS OF NEUROLOGY
- Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease
- (2009) Fabienne Brilot et al. ANNALS OF NEUROLOGY
- Immunoglobulins and complement in postmortem multiple sclerosis tissue
- (2009) Michael H. Barnett et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis
- (2009) K. A. McLaughlin et al. JOURNAL OF IMMUNOLOGY
- Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals
- (2009) T. Derfuss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ganglioside antibodies and neuropathies
- (2008) Simon Rinaldi et al. CURRENT OPINION IN NEUROLOGY
- Myelinated, synapsing cultures of murine spinal cord - validation as anin vitromodel of the central nervous system
- (2008) C. E. Thomson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Astrocytes, but not olfactory ensheathing cells or Schwann cells, promote myelination of CNS axonsin vitro
- (2008) Annette Sorensen et al. GLIA
- Autoantibodies and neurodegeneration in multiple sclerosis
- (2008) Tamara Vyshkina et al. LABORATORY INVESTIGATION
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
- (2008) F. J. Quintana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resistance is futile: antineuronal autoimmunity in multiple sclerosis
- (2008) Ruth Huizinga et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started